These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 36381705)
1. Complete, Rapid Resolution of Severe Bilateral Pneumonia and Acute Respiratory Distress Syndrome in a COVID-19 Patient: Role for a Unique Therapeutic Combination of Inhalations With Bromhexine, Higher Doses of Colchicine, and Hymecromone. Mondeshki T; Bilyukov R; Tomov T; Mihaylov M; Mitev V Cureus; 2022 Oct; 14(10):e30269. PubMed ID: 36381705 [TBL] [Abstract][Full Text] [Related]
2. Effect of an Accidental Colchicine Overdose in a COVID-19 Inpatient With Bilateral Pneumonia and Pericardial Effusion. Mondeshki T; Bilyukov R; Mitev V Cureus; 2023 Mar; 15(3):e35909. PubMed ID: 37038575 [TBL] [Abstract][Full Text] [Related]
3. Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients. Tiholov R; Lilov AI; Georgieva G; Palaveev KR; Tashkov K; Mitev V Immun Inflamm Dis; 2024 May; 12(5):e1273. PubMed ID: 38798123 [TBL] [Abstract][Full Text] [Related]
4. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
6. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study. Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043 [TBL] [Abstract][Full Text] [Related]
7. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial. Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529 [TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial". Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395 [TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]
10. High-Dose Colchicine: Key Factor in the Treatment of Morbidly Obese COVID-19 Patients. Mondeshki T; Mitev V Cureus; 2024 Apr; 16(4):e58164. PubMed ID: 38741862 [TBL] [Abstract][Full Text] [Related]
11. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473 [TBL] [Abstract][Full Text] [Related]
12. Case Report: Potential Role of Corticosteroids in the Management of Post-COVID-19 Pneumonia. Aissaoui H; Eskenazi A; Suteau V; Adenis A; Drak Alsibai K Front Med (Lausanne); 2021; 8():686806. PubMed ID: 34568360 [TBL] [Abstract][Full Text] [Related]
13. Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository. El-Solh AA; Meduri UG; Lawson Y; Carter M; Mergenhagen KA J Intensive Care Med; 2021 Jun; 36(6):664-672. PubMed ID: 33685275 [TBL] [Abstract][Full Text] [Related]